Covidien finalizes acquisition of Somanetics for $250M
Covidien said it closed on its purchase of Somanetics, which makes and markets noninvasive medical diagnostic and monitoring devices, for $250 million. Covidien's announcement comes weeks after it finalized its acquisition of ev3, a maker of devices used for treating peripheral vascular and neurovascular diseases, for $2.6 billion.
American City Business Journals | 07/28
This story published in AdvaMed SmartBrief on 07/29/2010
More from SmartBrief:
Covidien closes sale of sleep therapy line to PH Invest
Monday, August 30, 2010
DOE awards 7 grants to Radiation Monitoring Devices
Tuesday, August 24, 2010
Hologic completes $85M purchase of Sentinelle Medical
Monday, August 9, 2010
Get stories like these delivered daily for FREE:
|
AdvaMed SmartBrief
Designed specifically for manufacturers of medical devices, health care information systems and diagnostic products, AdvaMed SmartBrief is a FREE e-mail newsletter. By providing a summary of the day's most important medical technologies news, AdvaMed SmartBrief saves you time and keeps you smart. Learn more |
|